Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr

Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr

By: IPP Bureau

Last updated : August 13, 2023 7:43 pm



Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023


Aurobindo Pharma Limited has reported Consolidated financial results for the period ended June 30, 2023.

Aurobindo Pharma has posted net profit of Rs. 570.75 crores for the period ended June 30, 2023 as against net profit of Rs. 506.27 crores for the period ended March 31, 2023. The company posted net profit of Rs.520.54 crores for the period ended June 30, 2022.

Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023 as compared to Rs. 6607.87 crores during the period ended March 31, 2023. The company reported total income of Rs.6276.54 crores during the period ended June 30, 2022.

Aurobindo Pharma

First Published : August 13, 2023 12:00 am